Tag: Infliximab dyyb

Zymfentra (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, was approved by the FDA in October 2023. Yes, **is Zymfentra available in the USA**, having become commercially available nationwide in March 2024.

Approved by the FDA in October 2023, Zymfentra is the first and only subcutaneous formulation of infliximab available for maintenance treatment of inflammatory bowel disease (IBD). This innovative medication offers a new pathway for adult patients with moderate to severe Crohn’s disease or ulcerative colitis, providing a convenient, at-home option for long-term therapy.